BIIB
Biogen Inc.
223.60$
+1.7%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23.4% | 0.5% | 24.2% | 25.4% | 37.9% | 31.0% | 10.7% | 6.1% | 51.8% | 22.5% | 26.1% | 16.4% | 28.9% | |
| 4.9% | 5.9% | 6.4% | 6.4% | 7.4% | 7.5% | 7.5% | 7.3% | 8.2% | 8.8% | 8.2% | -7.5% | 4.0% | |
| 2.5% | 2.3% | 3.2% | 2.9% | 2.9% | 3.1% | 3.3% | 2.8% | 3.1% | 2.6% | 3.4% | -3.1% | 1.4% | |
| 12.4% | -27.2% | -10.0% | -7.7% | 9.5% | 1.2% | -13.7% | -29.8% | 7.1% | -4.8% | -5.2% | 4.7% | 0.7% | |
| 3.5% | 2.7% | 5.3% | 1.7% | 5.3% | 2.7% | 1.9% | 0.6% | 1.9% | 1.9% | 2.1% | 1.5% | 1.8% | |
| -68.8% | -27.0% | -2.9% | 18.9% | -47.9% | -0.8% | -1.9% | -2.2% | -1.4% | -54.0% | -8.5% | -140.3% | -53.4% | |
| 0.0% | 0.0% | – | 0.4% | -0.4% | – | – | – | – | – | – | – | – | |
| – | – | – | – | 0.0% | 0.0% | 0.0% | -0.6% | 0.0% | 0.0% | – | – | – | |
| 33.4% | -27.4% | -19.2% | -9.9% | -0.3% | 0.3% | -0.9% | -0.4% | -5.3% | -6.0% | -1.8% | 49.4% | 10.5% | |
| -13.0% | -51.9% | 1.1% | 33.9% | -8.5% | 27.5% | 9.2% | 6.1% | 45.0% | -37.6% | 15.1% | -74.7% | -14.3% | |
| 20.0% | -2.2% | 18.9% | 23.7% | 32.7% | 28.3% | 8.7% | 5.5% | 50.0% | 24.4% | 28.1% | 17.9% | 29.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.